SCHEMBL6986287

SCHEMBL6986287

CC(CCNC(=O)c1ccc(-c2cccs2)cc1)CC(=O)NC1(C)C(=O)COC1C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM4 P08173 1/20 0.39
HDAC1 Q13547 3/20 0.38
CTSS P25774 2/20 0.37
CTSB P07858 1/20 0.37
DRD4 P21917 8/20 0.37
DRD2 P14416 7/20 0.37
HTR2A P28223 4/20 0.37
DPP4 P27487 1/20 0.36
PREP P48147 1/20 0.36
HPGDS O60760 1/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
ATM Q13315 1/20 0.35
ERCC1 P07992 1/20 0.35
FEN1 P39748 1/20 0.35
ERCC4 Q92889 1/20 0.35
FYN P06241 1/20 0.35
CTSL P07711 1/20 0.34
CTSK P43235 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6985955 0.84 NAMPT (0.37) DPP4NPC1RAB9A
SCHEMBL6985875 0.84 LMNA (0.40) HDAC1NPC1RAB9ASMN1; SMN2CTSK
SCHEMBL6989326 0.83 RAB9A (0.38) NPC1RAB9ASMN1; SMN2CTSK
SCHEMBL6985259 0.83 HDAC1 (0.40) HDAC1DRD4DRD2NPC1RAB9A
SCHEMBL6987790 0.82 TAS1R3 (0.38) DRD4DRD2NPC1RAB9ASMN1; SMN2
SCHEMBL6987802 0.80 KMT2A (0.41) NPC1RAB9ASMN1; SMN2ATM
SCHEMBL6986218 0.80 TRPV1 (0.40)
SCHEMBL6990430 0.79 GCGR (0.41) DRD2HTR2A
SCHEMBL6751274 0.79 CTSK (0.50) CTSSCTSBHPGDSCTSLCTSK
SCHEMBL6988884 0.77 CTSS (0.36) CHRM4HDAC1CTSSCTSBDRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1362042-A1 CYCLIC 2-CARBONYLAMINOKETONES AS INHIBITORS OF CRUZIPAIN AND OTHER CYSTEINE PROTEASES Amura Therapeutics Limited (GB) 2003-11-19 EP disclosed
WO-2002057249-A1 CYCLIC 2-CARBONYLAMINOKETONES AS INHIBITORS OF CRUZIPAIN AND OTHER CYSTEINE PROTEASES AMURA THERAPEUTICS LIMITED (GB) 2002-07-25 WO disclosed